P126 Oral treatment with PBI-4050 ameliorates bleomycin-induced pulmonary fibrosis by reducing serum and lung anti-inflammatory/fibrotic biomarkers

Autor: Marie-Pier Cloutier, Martin Leduc, Brigitte Grouix, Shaun D. Abbott, Mikaël Tremblay, Alexandre Laverdure, Kathy Hince, Boulos Zacharie, Lyne Gagnon, Lilianne Geerts, Jean-Simon Duceppe, François Sarra-Bournet, Liette Gervais, Pierre Laurin
Rok vydání: 2016
Předmět:
Zdroj: QJM: An International Journal of Medicine.
ISSN: 1460-2393
Popis: PBI-4050 is a first-in-class orally active compound which displays antifibrotic activities in kidney, heart, liver, pancreas and lung models. PBI-4050 was found to be safe and well tolerated in healthy volunteers and in patients with CKD and Type 2 diabetes without any SAEs. Translation of pharmacological efficacy in humans …
Databáze: OpenAIRE